The risk for readmission in schizophrenia patients treated with long-acting injectable (typical or atypical) versus oral antipsychotics

被引：0
|
作者：
Onn, R. [1 ]
Krivoy, A. [1 ,2 ]
Weizman, A. [1 ,2 ]
Hochman, E. [1 ,2 ]
Valevski, A. [1 ,2 ]
机构：
[1] Geha Mental Hlth Ctr, Psychiat, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30676-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.027
引用
收藏
页码：S494 / S494
页数：1
相关论文
共 50 条
  • [31] In-Hospital Use of Long-Acting Injectable Antipsychotics and Readmission Risk in Patients With First-Admission Schizophrenia in Taiwan
    Chen, Wei
    Wu, Chi-Shin
    Liu, Chen-Chung
    Kuo, Po-Hsiu
    Chan, Hung-Yu
    Lin, Yi-Hsuan
    Chung, Yu-Chu Ella
    Chen, Wei J.
    JAMA NETWORK OPEN, 2024, 7 (06) : e2417006
  • [32] Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients' subjective experiences
    Aprile, Sofia Francesca
    Rodolico, Alessandro
    Di Francesco, Antonio
    Varrasi, Sofia
    Bighelli, Irene
    Castellano, Sabrina
    Signorelli, Maria Salvina
    Leucht, Stefan
    Caraci, Filippo
    PSYCHIATRY RESEARCH, 2025, 348
  • [33] Guidelines for the use of long-acting injectable atypical antipsychotics
    不详
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (01) : 120 - 131
  • [34] Long-acting, injectable risperidone a direct transition from oral atypical antipsychotics
    Schmauss, M
    Schreiner, A
    EUROPEAN PSYCHIATRY, 2005, 20 : S76 - S76
  • [35] Clinical and functional outcomes of patients with schizophrenia treated with risperidone long-acting injection versus oral antipsychotics
    Olivares, J. M.
    Morales, A. Rodriguez
    Diels, J.
    Povey, M.
    Lam, A.
    Zhao, Z.
    EUROPEAN PSYCHIATRY, 2008, 23 : S126 - S127
  • [36] Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychotics
    Kheloussi, Steven
    Oberlin Jr, John
    Trauger, Madison
    Testa, Nicholas D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (10): : 1130 - 1137
  • [37] Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review
    Zhornitsky, Simon
    Stip, Emmanuel
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
  • [38] Efficacy of Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations
    Thaman, Pragya
    Kulig, Caitlin E.
    Greer, Daniel
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (02) : 96 - 99
  • [39] Relapse with oral antipsychotics versus long-acting injectable antipsychotics: new paradoxical findings
    Jobe, Thomas H.
    Harrow, Martin
    EVIDENCE-BASED MENTAL HEALTH, 2014, 17 (03) : 84 - 84
  • [40] Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain
    Arango, Celso
    Baeza, Inmaculada
    Bernardo, Miquel
    Canas, Fernando
    de Dios, Consuelo
    Diaz-Marsa, Marina
    Paz Garcia-Portilla, Maria
    Gutierrez-Rojas, Luis
    Manuel Olivares, Jose
    Rico-Villademoros, Fernando
    Rodriguez-Jimenez, Roberto
    Maria Sanchez-Morla, Eva
    Segarra, Rafael
    Crespo-Facorro, Benedicto
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2019, 12 (02): : 92 - 105
12345